BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4734420)

  • 21. Acute reductions in serum testosterone levels by narcotics in the male rat: stereospecificity, blockade by naloxone and tolerance.
    Cicero TJ; Wilcox CE; Bell RD; Meyer ER
    J Pharmacol Exp Ther; 1976 Aug; 198(2):340-6. PubMed ID: 948030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agonistic properties of narcotic analgesics and antagonists on the electroencephalogram and behavior in the rat and their reversal by naloxone.
    Colasanti B; Khazan N
    Neuropharmacology; 1973 Jul; 12(7):619-27. PubMed ID: 4730371
    [No Abstract]   [Full Text] [Related]  

  • 23. Assays of antagonistic activity of narcotic antagonists in man.
    Gorodetzky CW
    Adv Biochem Psychopharmacol; 1973; 8(0):291-7. PubMed ID: 4604130
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic effects of select narcotic antagonists in mice.
    Nuite JA; Harris LS
    Adv Biochem Psychopharmacol; 1973; 8(0):417-25. PubMed ID: 4794888
    [No Abstract]   [Full Text] [Related]  

  • 25. Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors.
    Cui R; Suemaru K; Li B; Kohnomi S; Araki H
    Eur J Pharmacol; 2009 May; 609(1-3):74-7. PubMed ID: 19374878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of narcotic agents on temperature regulation.
    Ary M; Lomax P
    Adv Biochem Psychopharmacol; 1979; 20():429-51. PubMed ID: 38642
    [No Abstract]   [Full Text] [Related]  

  • 27. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists.
    Fraser HF
    Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of morphine, nalorphine, naloxone, pentazocine, cyclazocine and oxotremorine on the synthesis and release of acetylcholine by mouse cerebral cortex slices in vitro.
    Howes JF; Harris LS; Dewey WL
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):267-76. PubMed ID: 5453231
    [No Abstract]   [Full Text] [Related]  

  • 29. Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice.
    Taber RI; Greenhouse DD; Rendell JK; Irwin S
    J Pharmacol Exp Ther; 1969 Sep; 169(1):29-38. PubMed ID: 5804610
    [No Abstract]   [Full Text] [Related]  

  • 30. Morphine withdrawal increases intrinsic excitability of oxytocin neurons in morphine-dependent rats.
    Brown CH; Stern JE; Jackson KL; Bull PM; Leng G; Russell JA
    Eur J Neurosci; 2005 Jan; 21(2):501-12. PubMed ID: 15673449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine).
    Martin WR; Gorodetzky CW
    J Pharmacol Exp Ther; 1965 Dec; 150(3):437-42. PubMed ID: 5322321
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Brain acetylcholine levels and nociceptive threshold in frogs after the administration of morphine, nalorphine and naloxone.
    Nistri A; Pepeu G
    J Physiol; 1974 Aug; 241(1):51P-52P. PubMed ID: 4547429
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of narcotic analgesics and narcotic antagonists on ganglionic transmission in the rat.
    Forbes JE; Dewey WL
    Life Sci; 1976 Aug; 19(3):401-7. PubMed ID: 183075
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
    Mattila MJ; Alhava E; Mansner R
    Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
    [No Abstract]   [Full Text] [Related]  

  • 36. [The potential antinarcotic effects of guanfacine].
    Marusov IV; Bogdanov EG; Marusova IB
    Eksp Klin Farmakol; 1996; 59(3):24-7. PubMed ID: 8974578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activities of narcotic and narcotic-antagonist analgesics following the intraventricular injection of various substances.
    Calcutt CR; Spencer PS
    Br J Pharmacol; 1971 Feb; 41(2):401P-402P. PubMed ID: 5572300
    [No Abstract]   [Full Text] [Related]  

  • 38. Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.
    Glover EM; Davis M
    Psychopharmacology (Berl); 2008 Jun; 198(2):167-80. PubMed ID: 18324390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of acute and chronic morphine administration on brain acetylcholine levels in the rat.
    Large WA; Milton AS
    Br J Pharmacol; 1970 Feb; 38(2):451P-452P. PubMed ID: 5417879
    [No Abstract]   [Full Text] [Related]  

  • 40. [The discriminative stimulus properties of naloxone during dissociative learning in a Y maze in morphine-dependent rats].
    Bespalov AIu; Medvedev IO; Dravolina OA; Zvartau EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):96-105. PubMed ID: 10330710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.